- Clinically Proven Ingredients: This formula contains a synergistic mix of immune-supporting compounds, including Andrographis, Elderberry, two types of Echinacea, Vitamin D, Vitamin C, and Zinc.
-
Targeted Action Against Viral-Induced Senescence: ViraMedica’s senolytic ingredients focus on supporting viral-induced zombie cell clearance, while boosting immune function and resilience.
- Immune System Support: Ingredients work to promote white blood cell production, T1 and T2 balance, neutrophil migration, and phagocytosis, while potent antioxidants guard against oxidative stress.
- Quality Assurance: Manufactured in cGMP-certified facilities, ViraMedica adheres to NuMedica's rigorous quality standards, including an A+ certification from NSF for the six year in a row.
Combat "Zombie Cells" and Boost Immunity with ViraMedica
Share
Ever heard of "zombie cells"? These senescent cells refuse to follow the normal cell lifecycle, lingering in the body long past their usefulness and releasing harmful signals that can damage healthy cells. Triggered by aging, stress, and sometimes even infections, these “zombie” cells have recently been connected to long COVID, potentially playing a role in prolonged symptoms and immune challenges. As they accumulate, they drive inflammation, accelerate aging, and increase our risk of chronic health issues.
Fortunately, recent research has identified natural compounds, or senolytics, that help clear these dysfunctional cells and promote healthier aging. NuMedica’s latest immune-support product, ViraMedica, is packed with powerful natural senolytics like fisetin, luteolin, quercetin, and ginger to specifically target viral-induced senescence to remove through a process called phagocytosis and help make our immune system more efficient. This “zombie cell” defense formula supports cellular health and bolsters immunity, making it a powerful addition to any winter wellness plan.
How Senolytics Work
Senolytics effectively target and eliminates certain zombie cells through a process called phagocytosis. In this process, immune cells act like Pac-Man, devouring the harmful senescent cells, much like Pac-Man eats ghosts in the classic game as an analogy. By clearing out these dysfunctional cells, senolytics help restore balance and promote healthier cellular function, ultimately enhancing immune response and reducing chronic inflammation.
Fisetin and Quercetin as Senolytics
Most people have heard of quercetin before for its many benefits for allergies and immune function, but have not heard of Fisetin. Fisetin is a powerful bioflavonoid and senolytic. A 2018 study showed the fisetin was the most bioactive and powerful senolytic out of 10 different compounds tested. PMID: 30279143
Here is a chart below from the research paper attached that summarizes some of the senolytic properties of both fisetin and quercetin.
Why Choose ViraMedica?
As we approach winter, maintaining a robust immune system is crucial. ViraMedica, our new breakthrough product, stands out with its unique blend of clinically-proven ingredients designed to fortify the immune system against viral threats and support recovery from cold, flu, covid, and long COVID symptoms.*
Key Features of ViraMedica:
Dosing for ViraMedica
*Dosing- 3 caps daily for immune protection, and for acute illness 3caps 2x a day can be taken for up to 7 days. ViraMedica was designed to be taken at maintenance up to two months max duration at the maintenance dose, then pulsed accordingly based on patient's needs. However, these are just suggestions and you should also coordinate with your healthcare provider for individual medical advice.
Research References
1.
Yousefzadeh MJ, Zhu Y, McGowan SJ, et al. Fisetin is a senotherapeutic that extends health and lifespan. EBioMedicine. 2018;36:18-28. doi:10.1016/j.ebiom.2018.09.015
2.
Zhang L, Pitcher LE, Prahalad V, Niedernhofer LJ, Robbins PD. Targeting cellular senescence with senotherapeutics: senolytics and senomorphics. FEBS J. 2023;290(5):1362-1383. doi:10.1111/febs.16350
3.
Li Z, Tian M, Wang G, et al. Senotherapeutics: An emerging approach to the treatment of viral infectious diseases in the elderly. Front Cell Infect Microbiol. 2023;13:1098712. Published 2023 Mar 29. doi:10.3389/fcimb.2023.1098712
4.
Pastor-Fernández A, Bertos AR, Sierra-Ramírez A, et al. Treatment with the senolytics dasatinib/quercetin reduces SARS-CoV-2-related mortality in mice. Aging Cell. 2023;22(3):e13771. doi:10.1111/acel.13771